Psychiatry and Neurology, Neurology · Miami, FL
NPI
1518924729
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
9240 SW 72nd St, Suite 118
Miami, FL, 33173
Phone (305) 229-9899
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
313 services
Medicare patients, 2024
160
Average age 77
Drug cost, 2024
$1.4M
9,819 prescriptions
Company payments, 2025
$2,629
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlos A Garcia-Rivera was code 99214 (office e&m - established), 185 times for 116 patients. In total Carlos A Garcia-Rivera billed 313 services in 16 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 185 | 116 | $101.78 | $19K |
| 99204 Office E&M - New | Office | 48 | 48 | $128.89 | $6,187 |
By year: 2022 $48K for 391 services; 2023 $46K for 370 services; 2024 $36K for 313 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carlos A Garcia-Rivera prescribed most often to Medicare patients was Gabapentin, with 984 prescriptions and refills. In total Carlos A Garcia-Rivera wrote 9,819 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 984 | 2,471 | 332 | $22K |
| Memantine Hcl Generic | 923 | 2,268 | 344 | $20K |
| Memantine Hcl Er Memantine Hcl | 693 | 1,682 | 223 | $81K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 668 | 1,721 | 190 | $16K |
| Pregabalin Generic | 594 | 638 | 105 | $11K |
| Donepezil Hcl Generic | 588 | 1,604 | 194 | $5,293 |
| Quetiapine Fumarate Generic | 528 | 1,318 | 152 | $13K |
| Escitalopram Oxalate Generic | 445 | 1,109 | 153 | $3,284 |
| Ropinirole Hcl Generic | 328 | 824 | 97 | $8,505 |
| Botox Onabotulinumtoxina | 286 | 758 | 95 | $349K |
| Primidone Generic | 204 | 498 | 55 | $4,842 |
| Tizanidine Hcl Generic | 204 | 269 | 93 | $2,053 |
| Topiramate Generic | 177 | 425 | 51 | $1,316 |
| Cyclobenzaprine Hcl Generic | 172 | 186 | 63 | $1,006 |
| Clonazepam Generic | 164 | 166 | 34 | $1,373 |
Brand drugs: 890 claims; generic drugs: 8,913 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlos A Garcia-Rivera $2,629 ($2,629 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $1,055.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 52 | $1,055 |
| Argenx US, Inc. ARGX | 8 | $203 |
| Lilly USA, LLC LLY | 8 | $163 |
| SK Life Science, Inc. | 6 | $162 |
| Neurocrine BioSciences, Inc. NBIX | 6 | $124 |
| Pfizer Inc. PFE | 6 | $118 |
| Janssen Biotech, Inc. JNJ | 3 | $104 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $101 |
| Ge Healthcare GEHC | 5 | $95.8 |
| Merz Pharmaceuticals, LLC | 4 | $83.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.